Alembic Pharmaceuticals
APLLTDNSE

Alembic Pharmaceuticals

₹717.50-6.70 (0.93%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
704.50
Today’s high
728.20
52 week low
635.80
52 week high
1,107.90
Open price
715.00
Previous close
724.20
Live volume
44,865
Lower circuit
574.00
Upper circuit
861.00

Fundamentals

Market Cap
₹14,137Cr
ROE
11.93%
P/E Ratio(TTM)
22.59
EPS(TTM)
31.84
P/B Ratio
2.66
Dividend Yield
1.53%
Industry P/E
31.90
Book Value
270.62
Debt to Equity
0.28
Face Value
2

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About

Established in 1907, Alembic Pharmaceuticals is a prominent research-driven, integrated pharmaceutical company that specializes in producing generic medicines and active pharmaceutical ingredients (APIs) for global markets. The company's core mission is to improve healthcare worldwide by focusing on innovation, maintaining a strong commitment to quality, and building trust with patients and healthcare providers. It leverages its expertise in chemistry and formulation to create high-quality, affordable medicines, making healthcare more accessible to a wider population across the globe. Its operations are strategically structured into three key areas: selling branded medicines in India, exporting generic drugs internationally, and manufacturing Active Pharmaceutical Ingredients. Headquartered in Vadodara, Gujarat, the company operates several advanced, FDA-approved manufacturing facilities in Gujarat and Sikkim which form the backbone of its global supply capabilities. With 756 cumulative product filings across the world, Alembic has established a strong and expanding presence in both regulated and emerging international pharma markets.;
MD/CEO
Chirayu Amin
Founded in
1907
NSE symbol
APLLTD
Industry

Shareholding Pattern

Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Promoters
69.74%
Retail And Others
9.83%
Mutual Funds
8.18%
Other Domestic Institutions
8.00%
Foreign Institutions
4.25%

Mutual Funds Invested (4)

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
Natco PharmaNATCOPHARM
₹1,077.25
-26.95 (2.44%)
L
    H
    19,283.8612.42.23
    ₹1,390.10
    +18.70 (1.36%)
    L
      H
      19,230.4540.855.47
      ₹632.40
      +0.45 (0.07%)
      L
        H
        15,679.3528.753.66
        ₹892.30
        +1.50 (0.17%)
        L
          H
          14,212.7533.092.16
          Livesquawk
          Alembic Pharma gets US FDA approval for Paroxetine ER 12.5 mg tablets. This approval brings Alembic's total US ANDA approvals to 235.
          Livesquawk
          Alembic Pharmaceuticals gets USFDA final approval for Efinaconazole Topical Solution, 10%. The US market size for this treatment is estimated at $500 million.
          2026
          5
          Feb
          Quarterly Result
          Release date
          2025
          4
          Nov
          Quarterly Result
          Release date
          5
          Aug
          Quarterly Result
          Release date

          29
          Jul
          Dividend
          Ex date
          ₹11.00
          per share

          For each share you hold, you will receive ₹11.00
          Dividend amount₹11.00 per share
          Dividend TypeFinal
          Ex Date29 Jul ‘25
          Record Date29 Jul ‘25
          Announcement date6 May ‘25

          6
          May
          Dividend
          Announced
          ₹11.00
          per share

          For each share you hold, you will receive ₹11.00
          Dividend amount₹11.00 per share
          Dividend TypeFinal
          Ex Date29 Jul ‘25
          Record Date29 Jul ‘25
          Announcement date6 May ‘25
          2024

          15
          Jul
          Dividend
          Ex date
          ₹11.00
          per share

          For each share you hold, you will receive ₹11.00
          Dividend amount₹11.00 per share
          Dividend TypeFinal
          Ex Date15 Jul ‘24
          Record Date15 Jul ‘24
          Announcement date9 May ‘24

          9
          May
          Dividend
          Announced
          ₹11.00
          per share

          For each share you hold, you will receive ₹11.00
          Dividend amount₹11.00 per share
          Dividend TypeFinal
          Ex Date15 Jul ‘24
          Record Date15 Jul ‘24
          Announcement date9 May ‘24
          Events calendar
          View upcoming events in other stocks